Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIMABOTULINUMTOXINB vs RISANKIZUMAB-RZAA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIMABOTULINUMTOXINB vs RISANKIZUMAB-RZAA: Safety Overview

Metric RIMABOTULINUMTOXINB RISANKIZUMAB-RZAA
Total FAERS Reports 176 65,422
Deaths Reported 38 2,269
Death Rate 21.6% 3.5%
Hospitalizations 35 14,095
Average Patient Age 59.0 yrs 56.5 yrs
% Female Patients 68.6% 57.1%
Manufacturer Solstice Neurosciences, LLC N/A
Route INTRAMUSCULAR N/A
Marketing Status N/A Prescription